Researchers at the U.K. Health Security Agency estimated that one dose of the vaccine was 78% effective at protecting against infection 14 or more days after vaccination.
Some nations could be paying ten times the price of Paxlovid’s generic equivalent, as WHO chief calls for treatment access to battle acute and long COVID-19
Rich countries have secured almost three times as many courses of a World Health Organisation (WHO)-recommended COVID-19 medicine, Pfizer’s Paxlovid, according to new analysis from Oxfam and the People’s Vaccine Alliance.
On Thursday, the largest county in the United States said it is "strongly recommending" people wear face coverings in indoor public settings but stopped short of requiring them.
...the increased risk was among people who were not hospitalized: Of those who dealt with COVID-19 at home, just over 0.7% were later diagnosed with a first-time seizure or epilepsy. That compared with just under 0.5% of people who were sick at home with the flu.
Recent Comments